News
Boston Scientific (NYSE: BSX) announced today that it initiated a new trial to assess its Agent DCB compared to the standard ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback